nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—CYP2B6—malignant glioma	0.405	0.54	CbGaD
Venlafaxine—SLC6A3—malignant glioma	0.345	0.46	CbGaD
Venlafaxine—SLC6A3—telencephalic ventricle—malignant glioma	0.00288	0.141	CbGeAlD
Venlafaxine—Tramadol—CYP2B6—malignant glioma	0.00243	0.606	CrCbGaD
Venlafaxine—Paranoid reaction—Carmustine—malignant glioma	0.0018	0.0121	CcSEcCtD
Venlafaxine—Impaired healing—Carmustine—malignant glioma	0.00177	0.0119	CcSEcCtD
Venlafaxine—NPY1R—telencephalon—malignant glioma	0.00164	0.0804	CbGeAlD
Venlafaxine—Grand mal convulsion—Carmustine—malignant glioma	0.0016	0.0108	CcSEcCtD
Venlafaxine—Cyclopentolate—BCHE—malignant glioma	0.00158	0.394	CrCbGaD
Venlafaxine—Tongue discolouration—Temozolomide—malignant glioma	0.00153	0.0103	CcSEcCtD
Venlafaxine—Cerebral ischaemia—Temozolomide—malignant glioma	0.00153	0.0103	CcSEcCtD
Venlafaxine—Azotaemia—Carmustine—malignant glioma	0.00143	0.00965	CcSEcCtD
Venlafaxine—Haemorrhoids—Temozolomide—malignant glioma	0.00126	0.00845	CcSEcCtD
Venlafaxine—Myasthenia—Carmustine—malignant glioma	0.00122	0.00818	CcSEcCtD
Venlafaxine—Deep vein thrombosis—Temozolomide—malignant glioma	0.00121	0.00817	CcSEcCtD
Venlafaxine—Oral candidiasis—Carmustine—malignant glioma	0.0012	0.0081	CcSEcCtD
Venlafaxine—Aphasia—Carmustine—malignant glioma	0.00118	0.00793	CcSEcCtD
Venlafaxine—Oral candidiasis—Temozolomide—malignant glioma	0.00116	0.00782	CcSEcCtD
Venlafaxine—Cyst—Carmustine—malignant glioma	0.00114	0.00769	CcSEcCtD
Venlafaxine—Parosmia—Temozolomide—malignant glioma	0.00114	0.00766	CcSEcCtD
Venlafaxine—Aphasia—Temozolomide—malignant glioma	0.00114	0.00766	CcSEcCtD
Venlafaxine—Hypokinesia—Carmustine—malignant glioma	0.00113	0.00762	CcSEcCtD
Venlafaxine—Paranoia—Carmustine—malignant glioma	0.00112	0.00755	CcSEcCtD
Venlafaxine—Interstitial lung disease—Carmustine—malignant glioma	0.00108	0.00727	CcSEcCtD
Venlafaxine—Myopathy—Temozolomide—malignant glioma	0.00105	0.00709	CcSEcCtD
Venlafaxine—Lung disorder—Temozolomide—malignant glioma	0.00104	0.00702	CcSEcCtD
Venlafaxine—Interstitial lung disease—Temozolomide—malignant glioma	0.00104	0.00702	CcSEcCtD
Venlafaxine—Apathy—Temozolomide—malignant glioma	0.00103	0.00696	CcSEcCtD
Venlafaxine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00103	0.00696	CcSEcCtD
Venlafaxine—Flat affect—Temozolomide—malignant glioma	0.00102	0.0069	CcSEcCtD
Venlafaxine—Stupor—Carmustine—malignant glioma	0.00102	0.00689	CcSEcCtD
Venlafaxine—Scotoma—Carmustine—malignant glioma	0.00101	0.00677	CcSEcCtD
Venlafaxine—Vaginal haemorrhage—Temozolomide—malignant glioma	0.000997	0.00672	CcSEcCtD
Venlafaxine—Menorrhagia—Temozolomide—malignant glioma	0.000997	0.00672	CcSEcCtD
Venlafaxine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00098	0.0066	CcSEcCtD
Venlafaxine—Necrosis—Carmustine—malignant glioma	0.000973	0.00655	CcSEcCtD
Venlafaxine—Scotoma—Temozolomide—malignant glioma	0.000972	0.00655	CcSEcCtD
Venlafaxine—Otitis media—Temozolomide—malignant glioma	0.000948	0.00638	CcSEcCtD
Venlafaxine—Hyperaesthesia—Temozolomide—malignant glioma	0.00094	0.00633	CcSEcCtD
Venlafaxine—NPY1R—central nervous system—malignant glioma	0.000935	0.0457	CbGeAlD
Venlafaxine—Petechiae—Temozolomide—malignant glioma	0.000897	0.00604	CcSEcCtD
Venlafaxine—Speech disorder—Carmustine—malignant glioma	0.000888	0.00598	CcSEcCtD
Venlafaxine—Liver injury—Temozolomide—malignant glioma	0.000877	0.00591	CcSEcCtD
Venlafaxine—Accidental injury—Carmustine—malignant glioma	0.000863	0.00581	CcSEcCtD
Venlafaxine—Speech disorder—Temozolomide—malignant glioma	0.000858	0.00578	CcSEcCtD
Venlafaxine—Breast pain—Temozolomide—malignant glioma	0.000846	0.0057	CcSEcCtD
Venlafaxine—Amenorrhoea—Temozolomide—malignant glioma	0.00084	0.00566	CcSEcCtD
Venlafaxine—Thinking abnormal—Carmustine—malignant glioma	0.000834	0.00562	CcSEcCtD
Venlafaxine—Drug interaction—Carmustine—malignant glioma	0.000823	0.00554	CcSEcCtD
Venlafaxine—Leukocytosis—Carmustine—malignant glioma	0.000813	0.00547	CcSEcCtD
Venlafaxine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000812	0.00547	CcSEcCtD
Venlafaxine—Gait disturbance—Carmustine—malignant glioma	0.000782	0.00527	CcSEcCtD
Venlafaxine—SLC6A3—brainstem—malignant glioma	0.00078	0.0381	CbGeAlD
Venlafaxine—Coordination abnormal—Carmustine—malignant glioma	0.000778	0.00524	CcSEcCtD
Venlafaxine—Neck pain—Carmustine—malignant glioma	0.000773	0.00521	CcSEcCtD
Venlafaxine—Pulmonary embolism—Carmustine—malignant glioma	0.000764	0.00514	CcSEcCtD
Venlafaxine—Gait disturbance—Temozolomide—malignant glioma	0.000756	0.00509	CcSEcCtD
Venlafaxine—Coordination abnormal—Temozolomide—malignant glioma	0.000752	0.00506	CcSEcCtD
Venlafaxine—Respiratory failure—Temozolomide—malignant glioma	0.000752	0.00506	CcSEcCtD
Venlafaxine—NPY1R—brain—malignant glioma	0.000742	0.0363	CbGeAlD
Venlafaxine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000738	0.00497	CcSEcCtD
Venlafaxine—Pulmonary embolism—Temozolomide—malignant glioma	0.000738	0.00497	CcSEcCtD
Venlafaxine—Vaginal inflammation—Temozolomide—malignant glioma	0.000738	0.00497	CcSEcCtD
Venlafaxine—Depressed level of consciousness—Carmustine—malignant glioma	0.000737	0.00497	CcSEcCtD
Venlafaxine—Urinary incontinence—Carmustine—malignant glioma	0.000737	0.00497	CcSEcCtD
Venlafaxine—Candida infection—Carmustine—malignant glioma	0.000729	0.00491	CcSEcCtD
Venlafaxine—Neuropathy—Carmustine—malignant glioma	0.000717	0.00483	CcSEcCtD
Venlafaxine—Influenza like illness—Temozolomide—malignant glioma	0.000717	0.00483	CcSEcCtD
Venlafaxine—SLC6A4—brainstem—malignant glioma	0.000715	0.0349	CbGeAlD
Venlafaxine—Depressed level of consciousness—Temozolomide—malignant glioma	0.000713	0.0048	CcSEcCtD
Venlafaxine—Urinary incontinence—Temozolomide—malignant glioma	0.000713	0.0048	CcSEcCtD
Venlafaxine—Candida infection—Temozolomide—malignant glioma	0.000705	0.00475	CcSEcCtD
Venlafaxine—Vaginal infection—Temozolomide—malignant glioma	0.000697	0.00469	CcSEcCtD
Venlafaxine—Neuropathy—Temozolomide—malignant glioma	0.000693	0.00467	CcSEcCtD
Venlafaxine—Aplastic anaemia—Temozolomide—malignant glioma	0.000693	0.00467	CcSEcCtD
Venlafaxine—SLC6A3—telencephalon—malignant glioma	0.000692	0.0338	CbGeAlD
Venlafaxine—Gynaecomastia—Carmustine—malignant glioma	0.000683	0.0046	CcSEcCtD
Venlafaxine—Dry eye—Temozolomide—malignant glioma	0.000682	0.00459	CcSEcCtD
Venlafaxine—Abnormal vision—Carmustine—malignant glioma	0.000666	0.00449	CcSEcCtD
Venlafaxine—Mental disability—Carmustine—malignant glioma	0.000663	0.00446	CcSEcCtD
Venlafaxine—Abnormal vision—Temozolomide—malignant glioma	0.000644	0.00434	CcSEcCtD
Venlafaxine—Mental disability—Temozolomide—malignant glioma	0.00064	0.00431	CcSEcCtD
Venlafaxine—Thrombophlebitis—Carmustine—malignant glioma	0.00064	0.00431	CcSEcCtD
Venlafaxine—Diabetes mellitus—Carmustine—malignant glioma	0.000637	0.00429	CcSEcCtD
Venlafaxine—SLC6A4—telencephalon—malignant glioma	0.000634	0.031	CbGeAlD
Venlafaxine—SLC6A2—brainstem—malignant glioma	0.000629	0.0307	CbGeAlD
Venlafaxine—Thrombophlebitis—Temozolomide—malignant glioma	0.000619	0.00417	CcSEcCtD
Venlafaxine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000616	0.00415	CcSEcCtD
Venlafaxine—Eye pain—Carmustine—malignant glioma	0.000614	0.00414	CcSEcCtD
Venlafaxine—Gastroenteritis—Temozolomide—malignant glioma	0.000604	0.00407	CcSEcCtD
Venlafaxine—Injury—Carmustine—malignant glioma	0.000603	0.00406	CcSEcCtD
Venlafaxine—Vascular purpura—Temozolomide—malignant glioma	0.000599	0.00403	CcSEcCtD
Venlafaxine—Deafness—Temozolomide—malignant glioma	0.000599	0.00403	CcSEcCtD
Venlafaxine—Eye pain—Temozolomide—malignant glioma	0.000593	0.004	CcSEcCtD
Venlafaxine—Amnesia—Carmustine—malignant glioma	0.00059	0.00397	CcSEcCtD
Venlafaxine—Hot flush—Temozolomide—malignant glioma	0.000573	0.00386	CcSEcCtD
Venlafaxine—Amnesia—Temozolomide—malignant glioma	0.00057	0.00384	CcSEcCtD
Venlafaxine—Menopausal symptoms—Temozolomide—malignant glioma	0.000568	0.00382	CcSEcCtD
Venlafaxine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000568	0.00382	CcSEcCtD
Venlafaxine—Thirst—Temozolomide—malignant glioma	0.000563	0.00379	CcSEcCtD
Venlafaxine—SLC6A2—telencephalon—malignant glioma	0.000558	0.0273	CbGeAlD
Venlafaxine—Hyponatraemia—Carmustine—malignant glioma	0.000557	0.00375	CcSEcCtD
Venlafaxine—Purpura—Temozolomide—malignant glioma	0.000556	0.00374	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000554	0.00373	CcSEcCtD
Venlafaxine—Diplopia—Carmustine—malignant glioma	0.000554	0.00373	CcSEcCtD
Venlafaxine—Diplopia—Temozolomide—malignant glioma	0.000536	0.00361	CcSEcCtD
Venlafaxine—Face oedema—Carmustine—malignant glioma	0.000535	0.0036	CcSEcCtD
Venlafaxine—Affect lability—Temozolomide—malignant glioma	0.000527	0.00355	CcSEcCtD
Venlafaxine—Ataxia—Carmustine—malignant glioma	0.000521	0.00351	CcSEcCtD
Venlafaxine—Face oedema—Temozolomide—malignant glioma	0.000517	0.00348	CcSEcCtD
Venlafaxine—Liver function test abnormal—Carmustine—malignant glioma	0.000512	0.00345	CcSEcCtD
Venlafaxine—Mood swings—Temozolomide—malignant glioma	0.000508	0.00342	CcSEcCtD
Venlafaxine—Hypokalaemia—Carmustine—malignant glioma	0.000505	0.0034	CcSEcCtD
Venlafaxine—Ataxia—Temozolomide—malignant glioma	0.000504	0.00339	CcSEcCtD
Venlafaxine—Dehydration—Temozolomide—malignant glioma	0.000498	0.00336	CcSEcCtD
Venlafaxine—SLC6A3—midbrain—malignant glioma	0.000497	0.0243	CbGeAlD
Venlafaxine—Dry skin—Temozolomide—malignant glioma	0.000491	0.00331	CcSEcCtD
Venlafaxine—Muscular weakness—Carmustine—malignant glioma	0.000489	0.00329	CcSEcCtD
Venlafaxine—Hypokalaemia—Temozolomide—malignant glioma	0.000488	0.00328	CcSEcCtD
Venlafaxine—SLC6A3—spinal cord—malignant glioma	0.000485	0.0237	CbGeAlD
Venlafaxine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000482	0.00325	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000482	0.00325	CcSEcCtD
Venlafaxine—Dysphagia—Carmustine—malignant glioma	0.000479	0.00323	CcSEcCtD
Venlafaxine—Muscular weakness—Temozolomide—malignant glioma	0.000473	0.00318	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000473	0.00318	CcSEcCtD
Venlafaxine—Abdominal distension—Temozolomide—malignant glioma	0.000466	0.00314	CcSEcCtD
Venlafaxine—Dysphagia—Temozolomide—malignant glioma	0.000463	0.00312	CcSEcCtD
Venlafaxine—SLC6A4—midbrain—malignant glioma	0.000455	0.0223	CbGeAlD
Venlafaxine—Pancytopenia—Carmustine—malignant glioma	0.000455	0.00306	CcSEcCtD
Venlafaxine—ABCB1—blood vessel—malignant glioma	0.000453	0.0222	CbGeAlD
Venlafaxine—Neutropenia—Carmustine—malignant glioma	0.000448	0.00302	CcSEcCtD
Venlafaxine—ABCG2—telencephalon—malignant glioma	0.000446	0.0218	CbGeAlD
Venlafaxine—Bronchitis—Temozolomide—malignant glioma	0.000445	0.003	CcSEcCtD
Venlafaxine—SLC6A4—spinal cord—malignant glioma	0.000444	0.0217	CbGeAlD
Venlafaxine—Pancytopenia—Temozolomide—malignant glioma	0.00044	0.00296	CcSEcCtD
Venlafaxine—SLC6A2—medulla oblongata—malignant glioma	0.000439	0.0214	CbGeAlD
Venlafaxine—Neutropenia—Temozolomide—malignant glioma	0.000433	0.00292	CcSEcCtD
Venlafaxine—Dysuria—Temozolomide—malignant glioma	0.000433	0.00292	CcSEcCtD
Venlafaxine—Hyperglycaemia—Carmustine—malignant glioma	0.000432	0.00291	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00043	0.0029	CcSEcCtD
Venlafaxine—Pneumonia—Carmustine—malignant glioma	0.00043	0.00289	CcSEcCtD
Venlafaxine—Pollakiuria—Temozolomide—malignant glioma	0.000428	0.00288	CcSEcCtD
Venlafaxine—Erectile dysfunction—Temozolomide—malignant glioma	0.000426	0.00287	CcSEcCtD
Venlafaxine—Depression—Carmustine—malignant glioma	0.000426	0.00287	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000423	0.00285	CcSEcCtD
Venlafaxine—Weight increased—Temozolomide—malignant glioma	0.000421	0.00284	CcSEcCtD
Venlafaxine—Renal failure—Carmustine—malignant glioma	0.00042	0.00283	CcSEcCtD
Venlafaxine—Weight decreased—Temozolomide—malignant glioma	0.000419	0.00282	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Carmustine—malignant glioma	0.000419	0.00282	CcSEcCtD
Venlafaxine—Hyperglycaemia—Temozolomide—malignant glioma	0.000418	0.00281	CcSEcCtD
Venlafaxine—Stomatitis—Carmustine—malignant glioma	0.000416	0.0028	CcSEcCtD
Venlafaxine—Pneumonia—Temozolomide—malignant glioma	0.000415	0.0028	CcSEcCtD
Venlafaxine—Depression—Temozolomide—malignant glioma	0.000412	0.00277	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000409	0.00276	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000405	0.00273	CcSEcCtD
Venlafaxine—Stomatitis—Temozolomide—malignant glioma	0.000402	0.00271	CcSEcCtD
Venlafaxine—SLC6A3—central nervous system—malignant glioma	0.000393	0.0192	CbGeAlD
Venlafaxine—Sinusitis—Temozolomide—malignant glioma	0.000387	0.00261	CcSEcCtD
Venlafaxine—Haemoglobin—Carmustine—malignant glioma	0.000385	0.0026	CcSEcCtD
Venlafaxine—SLC6A3—cerebellum—malignant glioma	0.000384	0.0188	CbGeAlD
Venlafaxine—Haemorrhage—Carmustine—malignant glioma	0.000384	0.00258	CcSEcCtD
Venlafaxine—Hallucination—Carmustine—malignant glioma	0.000382	0.00257	CcSEcCtD
Venlafaxine—Hypoaesthesia—Carmustine—malignant glioma	0.000382	0.00257	CcSEcCtD
Venlafaxine—Haemoglobin—Temozolomide—malignant glioma	0.000373	0.00251	CcSEcCtD
Venlafaxine—Haemorrhage—Temozolomide—malignant glioma	0.000371	0.0025	CcSEcCtD
Venlafaxine—Hepatitis—Temozolomide—malignant glioma	0.000371	0.0025	CcSEcCtD
Venlafaxine—Visual impairment—Carmustine—malignant glioma	0.00037	0.00249	CcSEcCtD
Venlafaxine—Hallucination—Temozolomide—malignant glioma	0.000369	0.00248	CcSEcCtD
Venlafaxine—Hypoaesthesia—Temozolomide—malignant glioma	0.000369	0.00248	CcSEcCtD
Venlafaxine—Pharyngitis—Temozolomide—malignant glioma	0.000368	0.00248	CcSEcCtD
Venlafaxine—SLC6A4—central nervous system—malignant glioma	0.00036	0.0176	CbGeAlD
Venlafaxine—Visual impairment—Temozolomide—malignant glioma	0.000357	0.00241	CcSEcCtD
Venlafaxine—Flushing—Carmustine—malignant glioma	0.000356	0.0024	CcSEcCtD
Venlafaxine—Erythema multiforme—Temozolomide—malignant glioma	0.00035	0.00236	CcSEcCtD
Venlafaxine—ABCG2—medulla oblongata—malignant glioma	0.00035	0.0171	CbGeAlD
Venlafaxine—Tinnitus—Temozolomide—malignant glioma	0.000346	0.00233	CcSEcCtD
Venlafaxine—CYP2D6—brainstem—malignant glioma	0.000344	0.0168	CbGeAlD
Venlafaxine—Flushing—Temozolomide—malignant glioma	0.000344	0.00232	CcSEcCtD
Venlafaxine—Cardiac disorder—Temozolomide—malignant glioma	0.000344	0.00232	CcSEcCtD
Venlafaxine—Arrhythmia—Carmustine—malignant glioma	0.000343	0.00231	CcSEcCtD
Venlafaxine—Alopecia—Carmustine—malignant glioma	0.000339	0.00228	CcSEcCtD
Venlafaxine—Erythema—Carmustine—malignant glioma	0.000334	0.00225	CcSEcCtD
Venlafaxine—Chills—Temozolomide—malignant glioma	0.000333	0.00224	CcSEcCtD
Venlafaxine—Alopecia—Temozolomide—malignant glioma	0.000328	0.00221	CcSEcCtD
Venlafaxine—Back pain—Carmustine—malignant glioma	0.000323	0.00218	CcSEcCtD
Venlafaxine—Erythema—Temozolomide—malignant glioma	0.000323	0.00217	CcSEcCtD
Venlafaxine—ABCG2—midbrain—malignant glioma	0.00032	0.0157	CbGeAlD
Venlafaxine—SLC6A2—central nervous system—malignant glioma	0.000317	0.0155	CbGeAlD
Venlafaxine—Dysgeusia—Temozolomide—malignant glioma	0.000316	0.00213	CcSEcCtD
Venlafaxine—Vision blurred—Carmustine—malignant glioma	0.000315	0.00212	CcSEcCtD
Venlafaxine—Tremor—Carmustine—malignant glioma	0.000313	0.00211	CcSEcCtD
Venlafaxine—ABCG2—spinal cord—malignant glioma	0.000312	0.0153	CbGeAlD
Venlafaxine—SLC6A3—brain—malignant glioma	0.000312	0.0153	CbGeAlD
Venlafaxine—Back pain—Temozolomide—malignant glioma	0.000312	0.0021	CcSEcCtD
Venlafaxine—Anaemia—Carmustine—malignant glioma	0.000309	0.00208	CcSEcCtD
Venlafaxine—Agitation—Carmustine—malignant glioma	0.000307	0.00207	CcSEcCtD
Venlafaxine—CYP2D6—telencephalon—malignant glioma	0.000306	0.0149	CbGeAlD
Venlafaxine—Vision blurred—Temozolomide—malignant glioma	0.000304	0.00205	CcSEcCtD
Venlafaxine—Tremor—Temozolomide—malignant glioma	0.000302	0.00204	CcSEcCtD
Venlafaxine—Ill-defined disorder—Temozolomide—malignant glioma	0.000299	0.00202	CcSEcCtD
Venlafaxine—Leukopenia—Carmustine—malignant glioma	0.000299	0.00201	CcSEcCtD
Venlafaxine—Anaemia—Temozolomide—malignant glioma	0.000298	0.00201	CcSEcCtD
Venlafaxine—Agitation—Temozolomide—malignant glioma	0.000296	0.002	CcSEcCtD
Venlafaxine—Angioedema—Temozolomide—malignant glioma	0.000295	0.00199	CcSEcCtD
Venlafaxine—Malaise—Temozolomide—malignant glioma	0.000291	0.00196	CcSEcCtD
Venlafaxine—Vertigo—Temozolomide—malignant glioma	0.00029	0.00195	CcSEcCtD
Venlafaxine—Convulsion—Carmustine—malignant glioma	0.000289	0.00195	CcSEcCtD
Venlafaxine—Leukopenia—Temozolomide—malignant glioma	0.000289	0.00195	CcSEcCtD
Venlafaxine—Hypertension—Carmustine—malignant glioma	0.000288	0.00194	CcSEcCtD
Venlafaxine—SLC6A4—brain—malignant glioma	0.000286	0.014	CbGeAlD
Venlafaxine—Palpitations—Temozolomide—malignant glioma	0.000285	0.00192	CcSEcCtD
Venlafaxine—Myalgia—Carmustine—malignant glioma	0.000284	0.00191	CcSEcCtD
Venlafaxine—Chest pain—Carmustine—malignant glioma	0.000284	0.00191	CcSEcCtD
Venlafaxine—Anxiety—Carmustine—malignant glioma	0.000283	0.00191	CcSEcCtD
Venlafaxine—Cough—Temozolomide—malignant glioma	0.000282	0.0019	CcSEcCtD
Venlafaxine—Convulsion—Temozolomide—malignant glioma	0.00028	0.00188	CcSEcCtD
Venlafaxine—Hypertension—Temozolomide—malignant glioma	0.000279	0.00188	CcSEcCtD
Venlafaxine—Confusional state—Carmustine—malignant glioma	0.000275	0.00185	CcSEcCtD
Venlafaxine—Myalgia—Temozolomide—malignant glioma	0.000275	0.00185	CcSEcCtD
Venlafaxine—Arthralgia—Temozolomide—malignant glioma	0.000275	0.00185	CcSEcCtD
Venlafaxine—Anxiety—Temozolomide—malignant glioma	0.000274	0.00184	CcSEcCtD
Venlafaxine—Oedema—Carmustine—malignant glioma	0.000272	0.00184	CcSEcCtD
Venlafaxine—Discomfort—Temozolomide—malignant glioma	0.000271	0.00183	CcSEcCtD
Venlafaxine—Infection—Carmustine—malignant glioma	0.000271	0.00182	CcSEcCtD
Venlafaxine—ABCB1—embryo—malignant glioma	0.00027	0.0132	CbGeAlD
Venlafaxine—Dry mouth—Temozolomide—malignant glioma	0.000269	0.00181	CcSEcCtD
Venlafaxine—Thrombocytopenia—Carmustine—malignant glioma	0.000267	0.0018	CcSEcCtD
Venlafaxine—Tachycardia—Carmustine—malignant glioma	0.000266	0.00179	CcSEcCtD
Venlafaxine—Confusional state—Temozolomide—malignant glioma	0.000265	0.00179	CcSEcCtD
Venlafaxine—Anaphylactic shock—Temozolomide—malignant glioma	0.000263	0.00177	CcSEcCtD
Venlafaxine—Oedema—Temozolomide—malignant glioma	0.000263	0.00177	CcSEcCtD
Venlafaxine—Infection—Temozolomide—malignant glioma	0.000262	0.00176	CcSEcCtD
Venlafaxine—Anorexia—Carmustine—malignant glioma	0.00026	0.00175	CcSEcCtD
Venlafaxine—Thrombocytopenia—Temozolomide—malignant glioma	0.000258	0.00174	CcSEcCtD
Venlafaxine—Hypotension—Carmustine—malignant glioma	0.000255	0.00171	CcSEcCtD
Venlafaxine—Hyperhidrosis—Temozolomide—malignant glioma	0.000255	0.00171	CcSEcCtD
Venlafaxine—SLC6A2—brain—malignant glioma	0.000252	0.0123	CbGeAlD
Venlafaxine—Anorexia—Temozolomide—malignant glioma	0.000251	0.00169	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000248	0.00167	CcSEcCtD
Venlafaxine—ABCG2—cerebellum—malignant glioma	0.000248	0.0121	CbGeAlD
Venlafaxine—Insomnia—Carmustine—malignant glioma	0.000246	0.00166	CcSEcCtD
Venlafaxine—Paraesthesia—Carmustine—malignant glioma	0.000245	0.00165	CcSEcCtD
Venlafaxine—Dyspnoea—Carmustine—malignant glioma	0.000243	0.00164	CcSEcCtD
Venlafaxine—Somnolence—Carmustine—malignant glioma	0.000242	0.00163	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00024	0.00162	CcSEcCtD
Venlafaxine—ABCB1—retina—malignant glioma	0.000239	0.0117	CbGeAlD
Venlafaxine—Insomnia—Temozolomide—malignant glioma	0.000238	0.0016	CcSEcCtD
Venlafaxine—Decreased appetite—Carmustine—malignant glioma	0.000237	0.0016	CcSEcCtD
Venlafaxine—Paraesthesia—Temozolomide—malignant glioma	0.000236	0.00159	CcSEcCtD
Venlafaxine—Dyspnoea—Temozolomide—malignant glioma	0.000235	0.00158	CcSEcCtD
Venlafaxine—Somnolence—Temozolomide—malignant glioma	0.000234	0.00158	CcSEcCtD
Venlafaxine—CYP2B6—central nervous system—malignant glioma	0.000234	0.0114	CbGeAlD
Venlafaxine—Constipation—Carmustine—malignant glioma	0.000233	0.00157	CcSEcCtD
Venlafaxine—Pain—Carmustine—malignant glioma	0.000233	0.00157	CcSEcCtD
Venlafaxine—Dyspepsia—Temozolomide—malignant glioma	0.000232	0.00156	CcSEcCtD
Venlafaxine—Decreased appetite—Temozolomide—malignant glioma	0.000229	0.00154	CcSEcCtD
Venlafaxine—Fatigue—Temozolomide—malignant glioma	0.000227	0.00153	CcSEcCtD
Venlafaxine—Pain—Temozolomide—malignant glioma	0.000225	0.00152	CcSEcCtD
Venlafaxine—Constipation—Temozolomide—malignant glioma	0.000225	0.00152	CcSEcCtD
Venlafaxine—Feeling abnormal—Carmustine—malignant glioma	0.000225	0.00151	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Carmustine—malignant glioma	0.000223	0.0015	CcSEcCtD
Venlafaxine—ABCB1—telencephalon—malignant glioma	0.00022	0.0107	CbGeAlD
Venlafaxine—Feeling abnormal—Temozolomide—malignant glioma	0.000217	0.00146	CcSEcCtD
Venlafaxine—Body temperature increased—Carmustine—malignant glioma	0.000215	0.00145	CcSEcCtD
Venlafaxine—Abdominal pain—Carmustine—malignant glioma	0.000215	0.00145	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000215	0.00145	CcSEcCtD
Venlafaxine—Urticaria—Temozolomide—malignant glioma	0.000209	0.00141	CcSEcCtD
Venlafaxine—Body temperature increased—Temozolomide—malignant glioma	0.000208	0.0014	CcSEcCtD
Venlafaxine—Abdominal pain—Temozolomide—malignant glioma	0.000208	0.0014	CcSEcCtD
Venlafaxine—ABCG2—brain—malignant glioma	0.000201	0.00984	CbGeAlD
Venlafaxine—Hypersensitivity—Carmustine—malignant glioma	0.000201	0.00135	CcSEcCtD
Venlafaxine—Asthenia—Carmustine—malignant glioma	0.000195	0.00132	CcSEcCtD
Venlafaxine—Hypersensitivity—Temozolomide—malignant glioma	0.000194	0.00131	CcSEcCtD
Venlafaxine—Asthenia—Temozolomide—malignant glioma	0.000189	0.00127	CcSEcCtD
Venlafaxine—Diarrhoea—Carmustine—malignant glioma	0.000186	0.00126	CcSEcCtD
Venlafaxine—Pruritus—Temozolomide—malignant glioma	0.000186	0.00125	CcSEcCtD
Venlafaxine—CYP2B6—brain—malignant glioma	0.000186	0.00907	CbGeAlD
Venlafaxine—Dizziness—Carmustine—malignant glioma	0.00018	0.00121	CcSEcCtD
Venlafaxine—Diarrhoea—Temozolomide—malignant glioma	0.00018	0.00121	CcSEcCtD
Venlafaxine—CYP3A4—central nervous system—malignant glioma	0.000177	0.00863	CbGeAlD
Venlafaxine—Dizziness—Temozolomide—malignant glioma	0.000174	0.00117	CcSEcCtD
Venlafaxine—CYP2D6—central nervous system—malignant glioma	0.000174	0.00849	CbGeAlD
Venlafaxine—Vomiting—Carmustine—malignant glioma	0.000173	0.00117	CcSEcCtD
Venlafaxine—ABCB1—medulla oblongata—malignant glioma	0.000173	0.00844	CbGeAlD
Venlafaxine—Rash—Carmustine—malignant glioma	0.000172	0.00116	CcSEcCtD
Venlafaxine—Dermatitis—Carmustine—malignant glioma	0.000172	0.00116	CcSEcCtD
Venlafaxine—Headache—Carmustine—malignant glioma	0.000171	0.00115	CcSEcCtD
Venlafaxine—CYP2D6—cerebellum—malignant glioma	0.00017	0.0083	CbGeAlD
Venlafaxine—Vomiting—Temozolomide—malignant glioma	0.000167	0.00113	CcSEcCtD
Venlafaxine—Rash—Temozolomide—malignant glioma	0.000166	0.00112	CcSEcCtD
Venlafaxine—Dermatitis—Temozolomide—malignant glioma	0.000166	0.00112	CcSEcCtD
Venlafaxine—Headache—Temozolomide—malignant glioma	0.000165	0.00111	CcSEcCtD
Venlafaxine—Nausea—Carmustine—malignant glioma	0.000162	0.00109	CcSEcCtD
Venlafaxine—ABCB1—midbrain—malignant glioma	0.000158	0.00772	CbGeAlD
Venlafaxine—Nausea—Temozolomide—malignant glioma	0.000156	0.00105	CcSEcCtD
Venlafaxine—ABCB1—spinal cord—malignant glioma	0.000154	0.00753	CbGeAlD
Venlafaxine—CYP2D6—brain—malignant glioma	0.000138	0.00674	CbGeAlD
Venlafaxine—ABCB1—central nervous system—malignant glioma	0.000125	0.00611	CbGeAlD
Venlafaxine—ABCB1—cerebellum—malignant glioma	0.000122	0.00597	CbGeAlD
Venlafaxine—ABCB1—brain—malignant glioma	9.92e-05	0.00485	CbGeAlD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.14e-05	0.000404	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NOTCH1—malignant glioma	3.13e-05	0.000402	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ASMT—malignant glioma	3.11e-05	0.0004	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CD80—malignant glioma	3.06e-05	0.000394	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—APC—malignant glioma	3.06e-05	0.000393	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CG—malignant glioma	3.06e-05	0.000393	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.04e-05	0.000391	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TNF—malignant glioma	3.03e-05	0.00039	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP2B6—malignant glioma	3.03e-05	0.000389	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGF—malignant glioma	3.02e-05	0.000389	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	3.01e-05	0.000387	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTPN11—malignant glioma	3e-05	0.000386	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—BCAN—malignant glioma	2.93e-05	0.000376	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	2.92e-05	0.000375	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—RTEL1—malignant glioma	2.9e-05	0.000372	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	2.89e-05	0.000371	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—BRAF—malignant glioma	2.87e-05	0.00037	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	2.87e-05	0.000368	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.83e-05	0.000363	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT2—malignant glioma	2.8e-05	0.00036	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—malignant glioma	2.79e-05	0.000358	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—IDH1—malignant glioma	2.77e-05	0.000356	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—COX8A—malignant glioma	2.77e-05	0.000356	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—COX8A—malignant glioma	2.7e-05	0.000347	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CD—malignant glioma	2.69e-05	0.000346	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SPHK1—malignant glioma	2.68e-05	0.000344	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CA—malignant glioma	2.66e-05	0.000342	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—KRAS—malignant glioma	2.63e-05	0.000338	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP2C18—malignant glioma	2.62e-05	0.000337	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	2.61e-05	0.000335	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—FGF2—malignant glioma	2.57e-05	0.000331	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—COX8A—malignant glioma	2.55e-05	0.000327	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—COX8A—malignant glioma	2.52e-05	0.000324	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.47e-05	0.000318	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	2.46e-05	0.000316	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CA—malignant glioma	2.42e-05	0.000311	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MDM2—malignant glioma	2.41e-05	0.00031	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RAF1—malignant glioma	2.4e-05	0.000309	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ERBB2—malignant glioma	2.37e-05	0.000305	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—IDH2—malignant glioma	2.36e-05	0.000303	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ASMT—malignant glioma	2.35e-05	0.000302	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CB—malignant glioma	2.34e-05	0.000301	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.33e-05	0.0003	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.3e-05	0.000296	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.3e-05	0.000295	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ASMT—malignant glioma	2.3e-05	0.000295	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	2.3e-05	0.000295	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.29e-05	0.000294	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.27e-05	0.000291	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.26e-05	0.00029	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL8—malignant glioma	2.25e-05	0.000289	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	2.22e-05	0.000285	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—BCAN—malignant glioma	2.21e-05	0.000284	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AKT1—malignant glioma	2.18e-05	0.00028	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ASMT—malignant glioma	2.16e-05	0.000278	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—BCAN—malignant glioma	2.16e-05	0.000278	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CASP3—malignant glioma	2.16e-05	0.000277	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—malignant glioma	2.15e-05	0.000277	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ASMT—malignant glioma	2.15e-05	0.000276	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTT1—malignant glioma	2.12e-05	0.000273	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.11e-05	0.000271	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.1e-05	0.00027	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.07e-05	0.000266	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.06e-05	0.000264	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—malignant glioma	2.04e-05	0.000262	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—BCAN—malignant glioma	2.03e-05	0.000262	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—IDH1—malignant glioma	2.03e-05	0.000261	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTEN—malignant glioma	2.03e-05	0.00026	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—BCAN—malignant glioma	2.02e-05	0.000259	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.01e-05	0.000258	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS1—malignant glioma	1.99e-05	0.000256	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AKT1—malignant glioma	1.98e-05	0.000254	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SPHK1—malignant glioma	1.96e-05	0.000252	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.93e-05	0.000248	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.92e-05	0.000247	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—BCHE—malignant glioma	1.85e-05	0.000238	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—RAF1—malignant glioma	1.83e-05	0.000235	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—malignant glioma	1.83e-05	0.000235	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SLC5A5—malignant glioma	1.83e-05	0.000235	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT3—malignant glioma	1.81e-05	0.000233	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—IDH2—malignant glioma	1.78e-05	0.000229	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.75e-05	0.000224	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—IDH2—malignant glioma	1.74e-05	0.000224	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—malignant glioma	1.68e-05	0.000216	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.68e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.68e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.68e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—COX8A—malignant glioma	1.66e-05	0.000214	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—malignant glioma	1.65e-05	0.000212	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—IDH2—malignant glioma	1.64e-05	0.000211	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP2B6—malignant glioma	1.64e-05	0.00021	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—IDH2—malignant glioma	1.63e-05	0.000209	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.61e-05	0.000206	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.57e-05	0.000202	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTT1—malignant glioma	1.56e-05	0.0002	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KRAS—malignant glioma	1.55e-05	0.0002	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.54e-05	0.000198	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—IDH1—malignant glioma	1.53e-05	0.000197	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.53e-05	0.000197	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.53e-05	0.000197	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—IDH1—malignant glioma	1.5e-05	0.000192	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.5e-05	0.000192	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.48e-05	0.000191	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SPHK1—malignant glioma	1.48e-05	0.000191	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTP1—malignant glioma	1.47e-05	0.000189	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS1—malignant glioma	1.46e-05	0.000187	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.45e-05	0.000187	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SPHK1—malignant glioma	1.45e-05	0.000186	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CAT—malignant glioma	1.43e-05	0.000184	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CA—malignant glioma	1.43e-05	0.000184	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP2C18—malignant glioma	1.42e-05	0.000182	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ASMT—malignant glioma	1.42e-05	0.000182	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—IDH1—malignant glioma	1.41e-05	0.000181	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—IDH1—malignant glioma	1.4e-05	0.00018	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—malignant glioma	1.38e-05	0.000178	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.37e-05	0.000176	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.36e-05	0.000175	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.36e-05	0.000175	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—BCHE—malignant glioma	1.36e-05	0.000174	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SPHK1—malignant glioma	1.35e-05	0.000174	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NCOR1—malignant glioma	1.35e-05	0.000174	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.34e-05	0.000172	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.34e-05	0.000172	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—BCAN—malignant glioma	1.33e-05	0.000171	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.33e-05	0.00017	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.32e-05	0.00017	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.25e-05	0.000161	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.25e-05	0.000161	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.21e-05	0.000155	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTT1—malignant glioma	1.18e-05	0.000151	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT1—malignant glioma	1.17e-05	0.00015	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTT1—malignant glioma	1.15e-05	0.000148	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.14e-05	0.000146	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.11e-05	0.000143	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CAV1—malignant glioma	1.1e-05	0.000142	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS1—malignant glioma	1.1e-05	0.000142	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.1e-05	0.000141	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.1e-05	0.000141	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.08e-05	0.000139	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTP1—malignant glioma	1.08e-05	0.000139	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS1—malignant glioma	1.08e-05	0.000138	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—IDH2—malignant glioma	1.07e-05	0.000138	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTT1—malignant glioma	1.07e-05	0.000138	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CAT—malignant glioma	1.05e-05	0.000135	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—BCHE—malignant glioma	1.02e-05	0.000132	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.01e-05	0.00013	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.01e-05	0.00013	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.01e-05	0.00013	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS1—malignant glioma	1e-05	0.000129	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CG—malignant glioma	1e-05	0.000129	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1e-05	0.000129	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—BCHE—malignant glioma	1e-05	0.000129	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NCOR1—malignant glioma	9.91e-06	0.000127	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC5A5—malignant glioma	9.88e-06	0.000127	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPARG—malignant glioma	9.69e-06	0.000125	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.57e-06	0.000123	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.48e-06	0.000122	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—BCHE—malignant glioma	9.42e-06	0.000121	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—BCHE—malignant glioma	9.34e-06	0.00012	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC5A5—malignant glioma	9.31e-06	0.00012	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC5A5—malignant glioma	9.23e-06	0.000119	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—IDH1—malignant glioma	9.22e-06	0.000119	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.1e-06	0.000117	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SPHK1—malignant glioma	8.92e-06	0.000115	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CD—malignant glioma	8.83e-06	0.000113	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.74e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.72e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.64e-06	0.000111	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.27e-06	0.000106	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTP1—malignant glioma	8.15e-06	0.000105	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CAV1—malignant glioma	8.08e-06	0.000104	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTP1—malignant glioma	7.95e-06	0.000102	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CAT—malignant glioma	7.93e-06	0.000102	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CAT—malignant glioma	7.74e-06	9.95e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CB—malignant glioma	7.69e-06	9.89e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—malignant glioma	7.62e-06	9.8e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.54e-06	9.69e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTP1—malignant glioma	7.5e-06	9.64e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NCOR1—malignant glioma	7.49e-06	9.63e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTP1—malignant glioma	7.43e-06	9.55e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CG—malignant glioma	7.36e-06	9.46e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NCOR1—malignant glioma	7.31e-06	9.4e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CAT—malignant glioma	7.29e-06	9.38e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CAT—malignant glioma	7.23e-06	9.3e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PPARG—malignant glioma	7.1e-06	9.13e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTT1—malignant glioma	7.07e-06	9.09e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NCOR1—malignant glioma	6.89e-06	8.85e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NCOR1—malignant glioma	6.83e-06	8.78e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTEN—malignant glioma	6.65e-06	8.54e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS1—malignant glioma	6.63e-06	8.52e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.47e-06	8.32e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—BCHE—malignant glioma	6.16e-06	7.92e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CAV1—malignant glioma	6.11e-06	7.85e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.08e-06	7.82e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CAV1—malignant glioma	5.96e-06	7.66e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.83e-06	7.5e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.64e-06	7.25e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CAV1—malignant glioma	5.62e-06	7.22e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—malignant glioma	5.59e-06	7.18e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CAV1—malignant glioma	5.57e-06	7.16e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.56e-06	7.15e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CG—malignant glioma	5.43e-06	6.98e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PPARG—malignant glioma	5.37e-06	6.9e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.32e-06	6.84e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PPARG—malignant glioma	5.24e-06	6.73e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.11e-06	6.57e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.07e-06	6.52e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PPARG—malignant glioma	4.94e-06	6.35e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTP1—malignant glioma	4.9e-06	6.3e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PPARG—malignant glioma	4.89e-06	6.29e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.89e-06	6.28e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTEN—malignant glioma	4.87e-06	6.26e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CD—malignant glioma	4.77e-06	6.13e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CAT—malignant glioma	4.77e-06	6.13e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CA—malignant glioma	4.69e-06	6.03e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.5e-06	5.79e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.5e-06	5.78e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.46e-06	5.73e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.26e-06	5.48e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—malignant glioma	4.22e-06	5.43e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CB—malignant glioma	4.16e-06	5.35e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—malignant glioma	4.12e-06	5.3e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.92e-06	5.04e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.89e-06	4.99e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.88e-06	4.99e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.85e-06	4.95e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AKT1—malignant glioma	3.83e-06	4.92e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTEN—malignant glioma	3.68e-06	4.73e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CAV1—malignant glioma	3.67e-06	4.72e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTEN—malignant glioma	3.59e-06	4.62e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.44e-06	4.42e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTEN—malignant glioma	3.39e-06	4.35e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTEN—malignant glioma	3.36e-06	4.32e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.34e-06	4.3e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PPARG—malignant glioma	3.23e-06	4.15e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.94e-06	3.78e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AKT1—malignant glioma	2.81e-06	3.61e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.6e-06	3.34e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.56e-06	3.29e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.54e-06	3.26e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CA—malignant glioma	2.54e-06	3.26e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.39e-06	3.07e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.37e-06	3.04e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTEN—malignant glioma	2.21e-06	2.85e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AKT1—malignant glioma	2.12e-06	2.73e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AKT1—malignant glioma	2.07e-06	2.66e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AKT1—malignant glioma	1.95e-06	2.51e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AKT1—malignant glioma	1.93e-06	2.49e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.56e-06	2.01e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AKT1—malignant glioma	1.28e-06	1.64e-05	CbGpPWpGaD
